|
Market Closed -
Xetra
12:35:04 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 2.970 EUR | +3.27% |
|
+3.92% | -45.50% |
| 10-16 | Evotec SE : Berenberg reiterates its Neutral rating | ZD |
| 10-15 | Evotec SE : Gets a Neutral rating from Deutsche Bank | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 570M | - | ||||
| 63.48B | |||||
| 54.55B | |||||
| 53.59B | |||||
| 44.75B | |||||
| 41.62B |
- Stock Market
- Stocks
- EVT Stock
- Charts Evotec SE
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
